AI Cracks a New Alzheimer’s Mystery

What if the real driver of Alzheimer’s disease has been hiding in plain sight—right inside your cells?

A groundbreaking new study from the University of California San Diego has done something that could change everything we thought we knew about Alzheimer’s… and they couldn’t have done it without the help of artificial intelligence.

We’ve discussed the pros and cons of AI in medicine before. And while many concerns remain, this latest finding shows just how powerful these tools can be when used with precision and purpose.

Because this time, AI helped researchers solve a mystery: how a gene long considered a marker of Alzheimer’s may actually be a cause of it.

The gene in question is called PHGDH. Until now, it was simply viewed as a possible early warning sign of Alzheimer’s.

But this new research proves something much bigger: PHGDH doesn’t just show up in Alzheimer’s—it may create it.

Here’s how…

PHGDH was known for producing a brain-supporting enzyme linked to the amino acid serine.

But when researchers tested whether its metabolic activity contributed to Alzheimer’s, the results were inconclusive.

So, they asked AI to model the gene’s three-dimensional structure—and what it revealed was stunning. PHGDH has a hidden DNA-binding domain—essentially a second, “moonlighting” function that allows it to disrupt the process your brain cells use to turn genes on and off.

This disruption leads to inflammation, memory problems, and the protein buildups that hallmark Alzheimer’s.

In short: PHGDH isn’t just a bystander. It’s a trigger.

Even more promising? Scientists identified a compound—NCT-503—that appears to target only this harmful side of PHGDH without affecting its beneficial functions. In mouse models, NCT-503 significantly slowed Alzheimer’s progression and improved memory and anxiety behaviors.

That’s huge—especially since current Alzheimer’s drugs often target plaques after the damage has been done. This treatment could strike before those plaques form.

Now, let’s be clear: this isn’t a cure… yet. More testing is needed. And animal models don’t always translate perfectly to human results.

As Big Pharma rushes to patent new molecules based on this finding (you can bet they will), it’s worth remembering: the real game-changer here was understanding why Alzheimer’s develops in the first place.

And that opens the door for early interventions—maybe even natural ones.

After all, controlling gene expression and inflammation isn’t something only drugs can do. Many natural brain protectors—like choline, curcumin, and lion’s mane mushroom—support these same pathways.

Pair that with a blood-sugar balanced diet, quality sleep, and stress management, and you’ve got a head start in protecting your brain.

We’ll continue following this story as it unfolds—and keep bringing you the latest breakthroughs, long before they hit the mainstream.

To early detection,

Rachel Mace
Managing Editorial Director, e-Alert
with contributions from the research team

P.S. Want to learn more about how natural medicine may help preserve memory and even reverse signs of decline? The Health Sciences Institute’s Brilliant Brain Protocol breaks down dozens of breakthrough discoveries that may halt Alzheimer’s in 28 days, and more. This protocol offers a complete roadmap to protecting your brain, naturally. Click here to learn more.